RESUMEN
OBJECTIVE: We sought to determine whether methylprednisolone, when administered to patients undergoing cardiac surgery, is able to ward off the detrimental hemodynamic and pulmonary alterations associated with cardiopulmonary bypass. METHODS: After institutional review board approval and informed consent was obtained, 90 patients scheduled for elective cardiac surgery were randomized to 1 of 3 groups. Group 30MP patients received 30 mg/kg intravenous methylprednisolone during sternotomy and 30 mg/kg during initiation of cardiopulmonary bypass, group 15MP patients received 15 mg/kg methylprednisolone at the same 2 times, and group NS patients received similar volumes of isotonic sodium chloride solution at the same 2 times. Perioperative care was standardized, and all caregivers were blinded to treatment group. Various hemodynamic and pulmonary measurements were obtained perioperatively, as well as fluid balance, weight, peak postoperative blood glucose level, and tracheal extubation time. RESULTS: Demographic and clinical characteristics of patients and intraoperative data were similar among the 3 groups. Patients receiving methylprednisolone (either dose) exhibited significantly increased cardiac index (P =.0006), significantly decreased systemic vascular resistance (P =.0005), and significantly increased shunt flow (P =.0020) during the immediate postoperative period. All 3 groups exhibited significant increases in alveolar-arterial oxygen gradient (P <.0001), significant decreases in dynamic lung compliance (P <.0001), and significant decreases in static lung compliance (P <.0001) during the immediate postoperative period, with no differences between groups. Perioperative fluid balance and weights were similar between groups. A statistically significant difference in peak postoperative blood glucose level existed (P =.016) among group NS (234 +/- 96 mg/dL), group 15MP (292 +/- 93 mg/dL), and group 30MP (311 +/- 90 mg/dL). In patients extubated within 12 hours of intensive care unit arrival, a statistically significant difference in extubation times existed (P =.025) between group NS (5.7 +/- 2.3 hours), group 15MP (5.9 +/- 2.2 hours), and group 30MP (7.5 +/- 2.7 hours). CONCLUSIONS: Methylprednisolone, as used in this investigation, offers no clinical benefits to patients undergoing elective coronary artery bypass grafting with cardiopulmonary bypass and may in fact be detrimental by initiating postoperative hyperglycemia and possibly hindering early postoperative tracheal extubation for undetermined reasons.
Asunto(s)
Antiinflamatorios/uso terapéutico , Puente de Arteria Coronaria , Intubación Intratraqueal , Hemisuccinato de Metilprednisolona/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Puente Cardiopulmonar , Femenino , Hemodinámica/efectos de los fármacos , Humanos , MasculinoRESUMEN
OBJECTIVE: To ascertain if protective ventilation can attenuate the damaging postoperative pulmonary effects of cardiopulmonary bypass (increases in airway pressure, decreases in lung compliance, and increases in shunt). DESIGN: Prospective, randomized clinical trial. SETTING: Single university hospital. PARTICIPANTS: Twenty-five patients undergoing elective coronary artery bypass graft procedure and early extubation. INTERVENTIONS: Thirteen patients received conventional mechanical ventilation (CV; respiratory rate, 8 breaths/min; tidal volume, 12 mL/kg; fraction of inspired oxygen [FIO2], 1.0; positive end-expiratory pressure [PEEP], +5), and 12 patients received protective mechanical ventilation (PV; respiratory rate, 16 breaths/min; tidal volume, 6 mL/kg; FIO2, 1.0; PEEP, +5). Perioperative anesthetic and surgical management were standardized. Various pulmonary parameters were determined twice perioperatively: 10 minutes after intubation and 60 minutes after arrival in the intensive care unit. MEASUREMENTS AND MAIN RESULTS: The mean postoperative increase in peak airway pressure in group CV was significantly larger than the mean postoperative increase in peak airway pressure in group PV (7.1 v 2.4 cm H2O; p < 0.001). Group CV experienced significant postoperative increases in plateau airway pressure (p = 0.007), but group PV did not (p = 0.644). The mean postoperative decrease in dynamic lung compliance in group CV was significantly larger than the mean postoperative decrease in dynamic lung compliance in group PV (14.9 v 5.5 mL/cm H2O; p = 0.002). Group CV experienced significant postoperative decreases in static lung compliance (p = 0.014), but group PV did not (p = 0.645). Group CV experienced significant postoperative increases in shunt (15.5% to 21.4%; p = 0.021), but group PV did not (18.4% to 21.2%; p = 0.265). CONCLUSIONS: Data indicate that protective ventilation decreases pulmonary damage caused by mechanical ventilation in normal and abnormal lungs. The results of this investigation indicate that protective ventilation may also help attenuate the postoperative pulmonary dysfunction (increases in airway pressure, decreases in lung compliance, and increases in shunt) commonly seen in patients after exposure to cardiopulmonary bypass.
Asunto(s)
Puente Cardiopulmonar/efectos adversos , Enfermedades Pulmonares/prevención & control , Complicaciones Posoperatorias/prevención & control , Respiración Artificial , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios ProspectivosRESUMEN
BACKGROUND: Proposed advantages of port-access cardiac surgery have yet to be substantiated. The authors retrospectively compared patients undergoing port-access cardiac surgery with a matched group undergoing conventional cardiac surgery. METHODS: Forty-six patients who underwent port-access cardiac surgery were matched with 46 who underwent conventional cardiac surgery. Absolute criteria for matching included morning-of-surgery admission, procedure undergone, and care being delivered by one of two surgeons. If possible, matching included care delivered by one of two anesthesiologists. Patients were matched as closely as possible for preoperative demographic and clinical characteristics. RESULTS: All 46 pairs of patients were matched for procedure and admitted the morning of surgery. All 92 operations were performed by one of two surgeons, and 89% were performed by one of two anesthesiologists. Preoperative demographic and clinical characteristics were equivalent between groups. Compared with conventional cardiac surgery, port-access cardiac surgery increased surgical complexity (it almost tripled cardiopulmonary bypass time during coronary artery bypass grafting and increased it almost 40% during mitral valve procedures) and increased total operating room time (P < 0.0001). Port-access cardiac surgery had no beneficial effect on earlier postoperative extubation, decreased incidence of atrial fibrillation, or intensive care unit time, yet it decreased postoperative duration of stay (P = 0.029, all patients), a benefit observed primarily in patients undergoing coronary artery bypass grafting (P = 0.002). CONCLUSIONS: This retrospective analysis revealed that port-access cardiac surgery increases surgical complexity, increases operating room time, has no effect on earlier postoperative extubation or decreased incidence of atrial fibrillation or intensive care unit time, and may facilitate postoperative hospital discharge (primarily in patients undergoing coronary artery bypass grafting). Properly designed prospective investigation is necessary to ascertain whether port-access cardiac surgery truly offers any benefits over conventional cardiac surgery.
Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Procedimientos Quirúrgicos Mínimamente Invasivos , Adulto , Anciano , Puente Cardiopulmonar , Femenino , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Quirófanos , Estudios Retrospectivos , Factores de TiempoRESUMEN
Surgical treatment of the combination of aneurysms of an aberrant right subclavian artery, distal aortic arch, and descending thoracic aorta requires control of structures in both the right and the left hemithorax. We report a 2-stage surgical approach. The 1st stage, performed through a median sternotomy, consists of an elephant trunk reconstruction and an interposition graft to the ligated aberrant right subclavian artery. The 2nd stage, performed through a left thoracotomy is an interposition graft from the elephant trunk to the distal descending thoracic aorta.
Asunto(s)
Aneurisma/cirugía , Aneurisma de la Aorta Torácica/cirugía , Arteria Subclavia/anomalías , Arteria Subclavia/cirugía , Aneurisma de la Aorta Torácica/complicaciones , Implantación de Prótesis Vascular , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Vasculares/métodosRESUMEN
UNLABELLED: We attempted to develop an insulin administration protocol that maintains normoglycemia in patients undergoing cardiac surgery and to study the effects of intraoperative blood glucose management on serum levels of creatine phosphokinase isoenzyme BB (CK-BB) and S-100 protein. Twenty nondiabetic patients were randomly allocated to receive either "tight control" of blood glucose with a standardized IV insulin infusion intraoperatively (Group TC) or "no control" of blood glucose intraoperatively (Group NC). Perioperative serum levels of glucose, CK-BB, and S-100 protein were determined in all patients. Group TC patients received 90.0 +/- 49.2 units of insulin, whereas Group NC patients received none. Despite insulin, both Group TC (P = 0.00026) and Group NC (P = 0.00003) experienced similar significant increases in blood glucose levels during hypothermic cardiopulmonary bypass. However, mean blood glucose level upon intensive care unit arrival was significantly decreased in Group TC, compared with Group NC (84.7 +/- 41.0 mg/dL, range 32-137 mg/dL vs 201.4 +/- 67.5 mg/dL, range 82-277 mg/dL, respectively; P = 0.0002). Forty percent of Group TC patients required treatment for postoperative hypoglycemia (blood glucose level <60 mg/dL). Substantial interindividual variability existed in regard to insulin resistance. The investigation was terminated after we realized that normoglycemia was unattainable with the study protocol and that postoperative hypoglycemia was unpredictable. All patients in both groups experienced similar significant increases in postoperative serum levels of CK-BB and S-100 protein. These results indicate that "tight control" of intraoperative blood glucose in nondiabetic patients undergoing cardiac surgery was unattainable with the study protocol and may initiate postoperative hypoglycemia. IMPLICATIONS: The appropriate intraoperative management of hyperglycemia and whether it adversely affects neurologic outcome in patients after cardiac surgery remains controversial. This investigation reveals that attempting to maintain normoglycemia in this setting with insulin may initiate postoperative hypoglycemia.
Asunto(s)
Glucemia/metabolismo , Puente Cardiopulmonar , Hipoglucemia/inducido químicamente , Insulina/administración & dosificación , Complicaciones Posoperatorias/inducido químicamente , Anciano , Puente de Arteria Coronaria , Creatina Quinasa/sangre , Femenino , Humanos , Hipoglucemia/terapia , Infusiones Intravenosas , Insulina/efectos adversos , Periodo Intraoperatorio , Isoenzimas , Masculino , Complicaciones Posoperatorias/terapia , Estudios Prospectivos , Proteínas S100/sangreRESUMEN
OBJECTIVE: To determine the dose of intrathecal (IT) morphine (along with the intraoperative baseline anesthetic) that provides significant analgesia yet does not delay extubation in the immediate postoperative period in patients undergoing cardiac surgery and early extubation. DESIGN: Prospective, randomized, double-blinded, placebo-controlled clinical study. SETTING: Single university hospital. PARTICIPANTS: Forty patients undergoing elective coronary artery bypass graft procedure and early extubation. INTERVENTIONS: Twenty patients received 10 microg/kg of IT morphine, and 20 patients received IT placebo. Perioperative anesthetic management was standardized and included postoperative patient-controlled morphine analgesia. MAIN RESULTS: Of the patients tracheally extubated during the immediate postoperative period, mean time to extubation was similar in patients who received IT morphine (6.8+/-2.8 h) or IT placebo (6.5+/-3.2 h). Four patients who received IT morphine had extubation substantially delayed because of prolonged ventilatory depression. There was no difference between groups in postoperative patient-controlled morphine analgesia use. CONCLUSION: Even when used in conjunction with an intraoperative baseline anesthetic that allows early extubation, IT morphine (10 microg/kg) was unable to provide substantial postoperative analgesia. The risks of using IT morphine in patients undergoing cardiac surgery and early extubation may outweigh the potential benefits.
Asunto(s)
Analgésicos Opioides/administración & dosificación , Puente de Arteria Coronaria , Intubación Intratraqueal , Morfina/administración & dosificación , Anciano , Analgesia Controlada por el Paciente , Anestesia General , Anestesia Raquidea , Método Doble Ciego , Femenino , Humanos , Inyecciones Espinales , Masculino , Persona de Mediana Edad , Dolor Postoperatorio/tratamiento farmacológico , Complicaciones Posoperatorias , Estudios ProspectivosRESUMEN
BACKGROUND: Whether or not methylprednisolone is beneficial during cardiac operation remains controversial. This study examines the effects of the drug on complement activation and hemodynamics in patients undergoing cardiac operation and early extubation. METHODS: Patients undergoing cardiac operation were randomized to receive either intravenous methylprednisolone (group MP) or intravenous placebo (group NS). Complement 3a (C3a) levels and hemodynamic parameters were obtained perioperatively. Extubation was accomplished at the earliest clinically appropriate time. RESULTS: Both groups exhibited equivalent increases in C3a levels after exposure to bypass. Group MP exhibited increased cardiac index, decreased systemic vascular resistance, and increased shunt flow when compared to group NS. More group MP patients required hemodynamic support and group MP patients had prolonged extubation times. CONCLUSIONS: Methylprednisolone was unable to attenuate complement activation and led to hemodynamic alterations (primarily vasodilation) that may hinder early extubation in patients after cardiac operations.
Asunto(s)
Puente de Arteria Coronaria , Glucocorticoides/farmacología , Hemodinámica/efectos de los fármacos , Intubación Intratraqueal/métodos , Metilprednisolona/farmacología , Adulto , Anciano , Activación de Complemento/efectos de los fármacos , Complemento C3a/análisis , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Resistencia Vascular/efectos de los fármacosRESUMEN
UNLABELLED: We compared the effect of three different asymmetric sternal retractors on brachial plexus dysfunction using intraoperative somatosensory evoked potentials (SSEPs). We studied 60 patients undergoing coronary bypass and internal mammary harvest. Assessment of brachial plexus function was performed pre- and postoperatively. Patients were assigned the use of a Pittman (MN Scientific Instruments Inc., Minneapolis, MN), Rultract (Rultract Inc., Cleveland, OH), or Delacroix-Chevalier (Delacroix-Chevalier, Paris, France) asymmetric sternal retractor for internal mammary exposure. SSEP changes from baseline during asymmetric retractor use and removal were determined, and average changes were compared among the retractor groups. Patient demographics and baseline SSEP values were similar. Fewer patients in the Delacroix-Chevalier group had decreases in SSEP amplitudes after retractor placement. Of the patients in the Rultract and Pittman groups, 45% and 25%, respectively, had amplitude decreases of >50%, compared with only 5% of the Delacroix-Chevalier patients. Three patients in both the Pittman and Rultract groups and one patient in the Delacroix-Chevalier group suffered brachial plexus symptoms postoperatively. We conclude that the Delacroix-Chevalier retractor is associated with less neurophysiologic evidence of brachial plexus dysfunction during asymmetric sternal retraction compared with either the Pittman or Rultract sternal retractors. IMPLICATIONS: We used somatosensory evoked potentials to assess the effect of several different asymmetric sternal retractors on brachial plexus dysfunction and to determine which produced the least evidence of nerve damage during surgical exposure of the internal mammary artery.
Asunto(s)
Plexo Braquial/fisiopatología , Potenciales Evocados Somatosensoriales/fisiología , Monitoreo Intraoperatorio , Esternón/cirugía , Toracotomía/instrumentación , Presión Sanguínea , Plexo Braquial/lesiones , Puente de Arteria Coronaria , Electrocardiografía , Electrodiagnóstico/instrumentación , Diseño de Equipo , Estudios de Seguimiento , Humanos , Complicaciones Intraoperatorias/prevención & control , Arterias Mamarias/cirugía , Nervio Mediano/fisiopatología , Persona de Mediana Edad , Parestesia/etiología , Complicaciones Posoperatorias , Tiempo de Reacción , Trastornos de la Sensación/etiología , Toracotomía/efectos adversosRESUMEN
Three areas involved with heparin-induced platelet activation (HIPA) need to be discussed from a cardiovascular surgeon's perspective. These include the clinical presentation and management of HIPA-associated events, preparation for surgery in patients with existing HIPA, and medical-legal considerations surrounding HIPA-associated events and treatment. The incidence of heparin-induced thrombocytopenia (HIT) is approximately 1% to 5% of surgical patients. As many as 35% of these patients experience heparin-induced thrombocytopenia and thrombosis syndrome (HITTS), which generally results in devastating outcomes. The initial management of all patients with HIT and HITTS involves withdrawal of heparin. Thereafter, treatment of HITTS should include aggressive interventions with antithrombin agents, plasmapheresis, and possibly thrombolytic agents. Surgery for patients with existing HIPA needs to be carefully planned. Once all nonsurgical avenues have been explored, surgery should be performed following proper planning and education of patient and family. Finally, the number of lawsuits directly related to outcomes in cases involving HIT and HITTS is increasing. Cardiovascular surgeons should be well prepared, limiting their exposure to potential litigation with good clinical management and complete clinical and laboratory documentation.
Asunto(s)
Heparina/efectos adversos , Cirugía Torácica , Trombocitopenia/inducido químicamente , Trombocitopenia/terapia , Procedimientos Quirúrgicos Cardiovasculares/efectos adversos , Humanos , Trombocitopenia/diagnósticoRESUMEN
UNLABELLED: Numerous clinical studies suggest that methylprednisolone may facilitate early tracheal extubation after cardiac surgery, yet no investigation has rigorously examined the use of the drug in this setting. In this prospective, randomized, double-blind, placebo-controlled study, we examined the pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting (CABG) and early tracheal extubation. Sixty patients undergoing elective CABG and early tracheal extubation were randomized into two groups. Group MP patients received i.v. methylprednisolone (30 mg/kg during sternotomy and 30 mg/kg during initiation of cardiopulmonary bypass) and Group NS patients received i.v. placebo at the same two times. Perioperative management was standardized. Alveolar-arterial (A-a) oxygen gradient, lung compliance, shunt, and dead space were determined four times perioperatively. Postoperative tracheal extubation was accomplished at the earliest appropriate time. Both groups exhibited significant postoperative increases in A-a oxygen gradient and shunt (P < 0.000001 for each group) and significant postoperative decreases in dynamic lung compliance (P < 0.000001 for each group). Patients in Group MP exhibited significantly larger increases in postoperative A-a oxygen gradient (P = 0.001) and shunt (P = 0.001) compared with patients in Group NS. Postoperative alterations in dynamic lung compliance, static lung compliance, and dead space were not statistically significant between the groups. The time to postoperative tracheal extubation was prolonged in Group MP patients compared with Group NS patients (769 +/- 294 vs 604 +/- 315 min, respectively; P = 0.05). Methylprednisolone was associated with larger increases in postoperative A-a oxygen gradient and shunt, was unable to prevent postoperative decreases in lung compliance, and prolonged extubation time, which indicate that use of the drug may hinder early tracheal extubation in patients after cardiac surgery. IMPLICATIONS: Traditionally, methylprednisolone has been administered to patients undergoing cardiac surgery to decrease postoperative pulmonary dysfunction. This study revealed that the drug is associated with larger increases in postoperative alveolar-arterial oxygen gradient and shunt and prolonged tracheal extubation time in patients undergoing coronary artery bypass grafting, which indicate that use of the drug may hinder early tracheal extubation.
Asunto(s)
Puente de Arteria Coronaria , Glucocorticoides/uso terapéutico , Intubación Intratraqueal/métodos , Pulmón/efectos de los fármacos , Metilprednisolona/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Fibrilación Atrial/etiología , Infarto Cerebral/etiología , Método Doble Ciego , Femenino , Humanos , Pulmón/fisiología , Masculino , Persona de Mediana Edad , Placebos , Estudios Prospectivos , Pruebas de Función Respiratoria , Factores de TiempoRESUMEN
Twenty-four patients required an intra-aortic balloon pump placed through the aortic arch during cardiac operations from 1985 to 1993. The operative procedures of the 24 patients requiring arch balloon pumps included aortocoronary bypass (14), redo aortocoronary bypass (3), valve replacement (3), aortocoronary bypass with concomitant ventricular septal defect repair (1), heart transplantation (2), and aortic to right ventricle fistula repair (1). Mortality was 54%. Morbidity included cerebral vascular accident (17%), acute renal failure (29%), left ventricular thrombus (4%), sternal wound infection (4%), and mediastinal exploration secondary to bleeding from the balloon pump site (4%). This review suggests that (1) mortality for patients requiring arch balloon is significant, (2) complications of cerebral vascular accident and renal failure may be increased, and (3) severe peripheral vascular disease is associated with arch balloon placement and subsequent increased morbidity and mortality.
Asunto(s)
Aorta Torácica/cirugía , Contrapulsador Intraaórtico/efectos adversos , Lesión Renal Aguda/etiología , Anciano , Anciano de 80 o más Años , Enfermedades de la Aorta/cirugía , Procedimientos Quirúrgicos Cardíacos , Causas de Muerte , Trastornos Cerebrovasculares/etiología , Puente de Arteria Coronaria , Femenino , Fístula/cirugía , Cardiopatías/cirugía , Implantación de Prótesis de Válvulas Cardíacas , Ventrículos Cardíacos/cirugía , Humanos , Contrapulsador Intraaórtico/instrumentación , Masculino , Mediastino/cirugía , Persona de Mediana Edad , Enfermedades Vasculares Periféricas/complicaciones , Hemorragia Posoperatoria/etiología , Reoperación , Esternón/cirugía , Infección de la Herida Quirúrgica/etiología , Trombosis/etiologíaRESUMEN
BACKGROUND: Diffuse or unresectable subaortic stenosis (SAS) necessitates an aggressive surgical approach for the elimination of left ventricular outflow tract obstruction. In this article we report our experience with the modified Konno-Rastan procedure, with inherent preservation of the native aortic valve and annulus, in the treatment of diffuse or unresectable SAS. METHODS: Sixteen children (age range, 21 months to 18 years) underwent the modified Konno-Rastan procedure through either a transventricular (n = 12) or a transatrial approach (n = 4) to the conal septum. Indications for operation were recurrent SAS (n = 3), hypertrophic obstructive cardiomyopathy (n = 3), tunnel stenosis (n = 2), SAS related to a canal (n = 3), and SAS after ventricular septal defect closure (n = 5). Eleven patients had undergone previous procedures and 5 underwent the modified Konno-Rastan procedure as their primary operation. RESULTS: The mean preoperative left ventricular outflow tract gradient of 50 +/- 17 mm Hg was reduced to 3 +/- 7 mm Hg (p < 0.001) after surgical repair. Postoperative complications included sternal infection (n = 1), heart block (n = 2), mediastinal bleeding (n = 1), and renal and cerebral ischemia (n = 1). There was 1 late postoperative death caused by pneumonia 2 years after operation (6.2% mortality rate). The mean follow-up period was 62 +/- 39 months and all patients had complete relief of preoperative symptoms and were in New York Heart Association class I. One patient underwent a successful redo modified Konno-Rastan procedure 7 years after the first operation for residual left ventricular outflow tract obstruction immediately below the aortic valve. One patient is awaiting reoperation for aortic incompetence unrelated to conal enlargement 1.5 years after the first procedure. CONCLUSIONS: The modified Konno-Rastan procedure represents an excellent therapy for diffuse or unresectable SAS in patients with a normal aortic valve. In addition, it produces excellent results in a limited number of patients with hypertrophic obstructive cardiomyopathy, in whom the Morrow procedure traditionally has been performed. Although it usually is performed through a transventricular approach, the modified Konno-Rastan procedure also can be performed through a transatrial approach; this is particularly useful in patients who have had previous ventricular septal defect closure associated with SAS occurring proximal to the prosthetic patch.
Asunto(s)
Estenosis de la Válvula Aórtica/cirugía , Adolescente , Válvula Aórtica/cirugía , Insuficiencia de la Válvula Aórtica/cirugía , Isquemia Encefálica/etiología , Cardiomiopatía Hipertrófica/cirugía , Niño , Preescolar , Estudios de Seguimiento , Bloqueo Cardíaco/etiología , Defectos del Tabique Interventricular/cirugía , Tabiques Cardíacos/cirugía , Humanos , Lactante , Isquemia/etiología , Riñón/irrigación sanguínea , Neumonía/etiología , Politetrafluoroetileno , Complicaciones Posoperatorias , Hemorragia Posoperatoria/etiología , Prótesis e Implantes , Recurrencia , Reoperación , Volumen Sistólico , Infección de la Herida Quirúrgica/etiología , Tasa de Supervivencia , Función Ventricular Izquierda , Obstrucción del Flujo Ventricular Externo/cirugíaRESUMEN
BACKGROUND: The Telectronics 330-801 atrial J (801) lead was recalled after reports implicated lead fracture/retention wire protrusion in patient mortality and morbidity. Recent reports suggest that 801 lead extraction may be associated with substantial morbidity and, possibly, excess mortality. We hypothesized that the 801 lead could be extracted using the subclavian approach with a high success rate and acceptable morbidity. METHODS: We analyzed the clinical outcomes in 60 consecutive patients who underwent 801 lead extraction. RESULTS: Sixty patients (34 women) with a mean age of 67 +/- 14.8 years had 18 class I, 13 class II, and 29 class III fractures. The lead age was 39 +/- 17 months. The subclavian approach was successful in 58 of 60 patients (96%). Complications, three major and eight minor, occurred in 10 of 60 patients (16%). All complications were successfully treated. There were no deaths. Only concurrent ventricular lead extraction was associated with complications (p = 0.008 by Fisher's exact test). CONCLUSIONS: Telectronics 801 leads can be successfully extracted using the subclavian approach with acceptable short-term morbidity, low mortality, and excellent long-term results.
Asunto(s)
Electrodos , Marcapaso Artificial , Prótesis e Implantes , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Atrios Cardíacos , Humanos , Masculino , Persona de Mediana Edad , Marcapaso Artificial/efectos adversos , Complicaciones Posoperatorias , Vena SubclaviaRESUMEN
This study compares the hands-up (HU) with the arms at side (AAS) position to determine whether one is beneficial in reducing brachial plexus stress during asymmetric sternal retraction. Eighty patients undergoing cardiac surgery were assigned to either Group 1 (AAS) or Group 2 (HU). Perioperative neurologic evaluations of the brachial plexus were performed and somatosensory evoked potentials (SSEPs) were collected during internal mammary artery harvest using asymmetric sternal retraction. Demographic data, SSEP changes, and postoperative brachial plexus symptoms were compared between groups. SSEP amplitude decreased in 95% of all patients during retractor placement with substantial decreases (> 50%) observed on the left side in 50% of the AAS and 35% of the HU patients. Amplitude recovery was normally seen in both groups after asymmetric retractor removal. Similar changes were noted, to a lesser degree, on the right side. During asymmetric sternal retraction, HU positioning offered minimal benefit in reducing brachial plexus stress as measured by SSEP. Three of the seven AAS patients who reported brachial plexus symptoms had an ulnar nerve distribution of injury. However, none of the four patients with plexus symptoms in the HU group had ulnar nerve problems, suggesting that the higher incidence of postoperative symptoms observed with AAS positioning may occur from ulnar nerve compression.
Asunto(s)
Brazo , Plexo Braquial/lesiones , Puente de Arteria Coronaria/efectos adversos , Arterias Mamarias/trasplante , Complicaciones Posoperatorias/prevención & control , Postura , Esternón/cirugía , Anciano , Puente de Arteria Coronaria/métodos , Potenciales Evocados Somatosensoriales , Humanos , Persona de Mediana Edad , Instrumentos QuirúrgicosRESUMEN
Pedicled omentoplasty is frequently used in chest reconstruction and treatment of sternal infection. The procedure is effective, but it is associated with several postoperative complications. The authors describe a 49-year-old man in whom sternal infection after heart surgery was successfully treated by sternectomy and omentoplasty. Several months later, the transverse colon herniated into the transposed omentum. To the authors' knowledge, this complication has not been previously reported.
Asunto(s)
Enfermedades del Colon/etiología , Epiplón/cirugía , Colgajos Quirúrgicos/efectos adversos , Hernia/etiología , Humanos , Masculino , Persona de Mediana Edad , Epiplón/diagnóstico por imagen , Tomografía Computarizada por Rayos XRESUMEN
Occasional patients have excessive defibrillation energy requirements despite appropriate transvenous defibrillation lead position and modification of defibrillation waveform and configuration. Preliminary data suggest that use of subcutaneous defibrillation electrode arrays with nonthoracotomy systems is associated with a substantial reduction in defibrillation threshold. The current operative approach to subcutaneous lead array implantation involves the use of a separate left chest incision. We present two cases in which implantation of a subcutaneous lead array in combination with a transvenous defibrillation electrode was performed via a single infraclavicular incision and associated with a reduction in defibrillation threshold. Such an approach simplifies implantation and avoids the potential morbidity of the additional incision required of a left lateral chest approach.
Asunto(s)
Desfibriladores Implantables , Anciano , Humanos , Masculino , Métodos , Persona de Mediana Edad , Taquicardia Ventricular/terapia , Fibrilación Ventricular/terapiaRESUMEN
The determinants of high defibrillation energy requirements (DER) using nonepicardial lead systems (NELS) have not been well characterized. The goal of this study was to examine prospectively the influence of clinical, radiographic, echocardiographic, and procedural variables on DER during NELS placement. Data from 100 consecutive patients undergoing attempted NELS implantation were analyzed. Transvenous leads, subcutaneous patches, and monophasic shock devices from two manufacturers were used. Leads were successfully positioned for testing in 95% of patients. An adequate DER (< or = 25 J) was obtained in 73 of 95 (77%) of patients. Univariate analysis identified amiodarone therapy and left ventricular mass as predictors of high DER. With multivariate analysis, amiodarone therapy was the sole significant predictor of high DER (P = 0.002, odds ratio 5.46). The 22 patients with high NELS DER also had high epicardial DER (mean 24 +/- 9 J). The two patch epicardial DER was > 25 joules in 12 of 22 patients. Thus, adequate DER with monophasic shock waveforms can be obtained in most patients undergoing NELS testing. However, amiodarone therapy significantly increases the probability of obtaining high DER.
Asunto(s)
Desfibriladores Implantables , Taquicardia Ventricular/terapia , Fibrilación Ventricular/terapia , Amiodarona/uso terapéutico , Cardioversión Eléctrica/métodos , Electrodos Implantados , Diseño de Equipo , Femenino , Humanos , Hipertrofia Ventricular Izquierda/fisiopatología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Prospectivos , Taquicardia Ventricular/fisiopatología , Fibrilación Ventricular/fisiopatologíaRESUMEN
BACKGROUND: The experience at Loyola University Chicago was retrospectively reviewed to evaluate survival and functional outcome after single lung transplantation (SLT) and bilateral lung transplantation (BLT). METHODS: Ninety patients underwent lung transplantation at Loyola University Chicago between April 1990 and December 1993. Mean age was 45 years (range, 13 to 66 years). Fifty percent were male. Pre-lung transplant pulmonary diseases were as follows: emphysema and/or chronic obstructive pulmonary disease in 43 patients, pulmonary fibrosis in 13, cystic fibrosis in 14, pulmonary hypertension in eight, repeated transplantation for obliterative bronchiolitis in four, bronchiectasis in two, bronchoalveolar cell carcinoma in two, sarcoidosis in one, primary obliterative bronchiolitis in one, histiocytosis X in one, and lymphangiomyomatosis in one. Fifty-seven patients underwent SLT, and 33 had BLT. Maintenance immunosuppression medications consisted of cyclosporine, azathioprine, and prednisone. RESULTS: Perioperative complications were as follows: seven of 33 patients bled after BLT, and two of 57 bled after SLT. Bronchial complications were found in six of 66 (9%) BLT anastomoses and eight of 57 (14%) SLT anastomoses. Nine operative deaths occurred in SLT patients: six from allograft failure, one from infection, one from intrapulmonary hemorrhage, and one from bronchial dehiscence. Only two patients died in the perioperative period after BLT and that was of infection. Three late deaths occurred after BLT, all as a result of infection; 13 recipients died late after SLT: five of infection, four patients from lymphoma, two of pancreatitis, one of tension pneumothorax, and one of pulmonary embolism. For the entire patient population the actuarial 1- and 2-year survival rates were 72% and 68%, respectively. One-year survival rates were significantly better for patients undergoing lung transplantation for obstructive and nonrestrictive lung diseases than those of patients undergoing lung transplantation for vascular or restrictive pulmonary disease. Recipients of BLT had a trend toward better survival than recipients of SLT. Lung function 6 months after transplantation measured by forced expiratory volume in 1 second was significantly better in BLT than SLT, 71% of predicted versus 54%. CONCLUSIONS: Patients who undergo BLT have significantly better postoperative pulmonary function than those who undergo SLT. On the basis of the study there was a trend toward better survival with BLT.